Exxon Mobil Says May Export LNG from the U.S.

Exxon Mobil, the world's largest publicly traded energy company, is considering exporting liquefied natural gas (LNG) from the United States, CEO Rex Tillerson said on Tuesday.

The company has been North America's largest natural gas producer since its 2010 purchase of XTO Energy, helped by a boom in output of shale gas.

Asked whether Exxon Mobil planned to export LNG from the United States, Tillerson said: "We are studying it."

U.S. natural gas prices have hit their lowest in a decade and are expected to remain low for years due in large part to ramped up production from shale reserves.

Tillerson confirmed the company was looking at building the new petrochemical plant in Texas to take advantage of cheap shale gas, but said it had not decided on the level of investment nor whether it would export petrochemicals.

"We will see where the markets are for those chemicals," he said, speaking at the World Gas Conference in the Malaysian capital.

The plant could be online as soon as 2016, according to a U.S. environmental filing seen by Reuters.

It would sharply crank up Exxon Mobil's chemical production capacity and help it compete more effectively with rival Dow Chemical, the largest U.S. chemical maker.

 

 

 

 

 

 

 

Interview

Innovation at the Intersection of AI
Digital Potential in Key Business Areas

Innovation at the Intersection of AI

Stefan Guertzgen spoke with John Banovetz, Chief Technology Officer at 3M, about the role of digital transformation in achieving the company's objectives.

Artificial Intelligence

Pierre Racz: "Real Artificial Intelligence Does Not Exist"
part one of a three-part interview series

Pierre Racz: "Real Artificial Intelligence Does Not Exist"

In part one Pierre Racz, President of Genetec, is addressing why IP network video systems were the game changer in the industry and why he does not like the term AI.

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.